Followers | 39 |
Posts | 1162 |
Boards Moderated | 0 |
Alias Born | 09/08/2013 |
Friday, January 31, 2014 1:38:28 PM
The company’s new approach to cell growth has already been applied to the repair of tendons and joints. The technology has also been applied to the re-growth of pancreas and heart tissue. Rejection does not occur as the new cells are from that individual and are recognized by the body as non foreign. It is believed that this new method of cell growth will be successfully used for cell and organ repair in many parts of the human body.
Therapy Cells has developed a novel and highly efficient method of growing tendon and articular cartilage for auto transplantation into individual, affected patients. The company has developed new cell theory that dispenses with the notion that cells cannot divide once they are fully mature. TCEL has shown that adult cells, given the right environment, can in fact divide and be grown in the laboratory.
Therapy Cell has developed a methodology that allows adult cells to divide and grow in controlled laboratory conditions. These new cells can then be used for transplantation back to damaged tissue to enact tissue and organ healing.
To date, the technology has been used for the growth and transplantation of:
Tendons and ligaments and Articular cartilage They have also applied this technology to successfully grow pancreatic cells, for treatment of diabetes, and cardiac cells for the treatment of heart disease, as well as other cell types from many other tissues.
Therapy Cells has shown that given the right culture conditions, these cell types can be grown into millions of new cells, and then successfully transplanted back into the injured tissue of the individual who has donated the cells, leading to tissue repair with one’s one cells.
The need for tissue and organ repair is growing. This is due to the continual growth of our population, coupled with individual needs to maintain good health. And, as our population grows, so does the number of older people seeking to maintain optimal activity levels
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM
Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM
SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • SBC • Nov 7, 2024 7:00 AM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM